Patent US5456260A successfully refreshed from Google Patents.
US5456260A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Fluorescence detection of cell proliferation
Assignee: General Hospital Corp
•
Filing: 1994-04-05
•
Granted: 1995-10-10
•
Expires: 2014-04-05
Abstract
Abstract The method of the present invention is directed at detecting non-invasively and in vivo the rate of proliferation of epithelial cells in a human patient. The method is based on determining the optical spectra, preferably the fluorescence excitation spectra, from affected and non-affected areas of epithelial cells, and then comparing the two spectra from these regions. In particular, applicants have discovered that when human or animal skin is irradiated with light centered near 295 nm, fluorescence having a distinct maximum near 360 nm is induced.
Inventors
- 👤 Nikiforos Kollias
- 👤 Robert Gillies
- 👤 R. Rox Anderson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 18:17
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/44; A61B5/441; A61B5/444; A61B5/0059; A61B5/0071; A61B5/445; G; G01; G01N; G01N21/00; G01N21/62; G01N21/63; G01N21/64; G01N21/6428
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
142 words
A method of detecting abnormal epithelial cell proliferation by monitoring tryptophan emission from the cell, said method comprising the steps of: (a) sequentially exposing the epithelial cell to a set of at least two different wavelengths of incident ultra-violet radiation that induce tryptophan present in the epithelial cell to sequentially emit at least two different emission patterns, (b) measuring and recording the intensities of each of said different emission patterns at an emission wavelength corresponding substantially to the maximum emission wavelength of tryptophan to generate a test intensity profile, (c) obtaining a normal emission intensity profile for tryptophan present in a normally proliferating epithelial cell, and comparing said test profile with said normal profile near the maximum tryptophan emission wavelength, with any difference in emission near said maximum tryptophan emission wavelength of the test profile indicating abnormal proliferation of the epithelial cell.
Claim 2
Independent Claim
142 words
A method of detecting abnormal epithelial cell proliferation by monitoring tryptophan emission from the cell, said method comprising the steps of: (a) sequentially exposing the epithelial cell to a set of at least two different wavelengths of incident ultra-violet radiation that induce tryptophan present in the epithelial cell to sequentially emit at least two different emission patterns, (b) measuring and recording the intensities of each of said different emission patterns at an emission wavelength corresponding substantially to the maximum emission wavelength of tryptophan to generate a test intensity profile, (c) obtaining a normal emission intensity profile for tryptophan present in a normally proliferating epithelial cell, and comparing said test profile with said normal profile near the maximum tryptophan emission wavelength, with any difference in emission near said maximum tryptophan emission wavelength of the test profile indicating abnormal proliferation of the epithelial cell.
Claim 3
Dependent Claim
107 words
The method of claim 1, further comprising the steps of: (d) sequentially re-exposing the epithelial cell to said set of incident ultra-violet radiation wavelengths, (e) measuring and recording the intensities of each of said different patterns at an emission wavelength other than the maximum tryptophan emission wavelength to generate a second test intensity profile, (f) obtaining a second normal fluorescence emission intensity profile for normal epithelial cell proliferation for said emission wavelength other than the maximum tryptophan emission wavelength, and comparing said second test profile with said second normal profile, any differences between said first profiles or said second profiles indicating abnormal proliferation of the epithelial cell.
Claim 4
Independent Claim
128 words
A method of detecting abnormal epithelial cell proliferation by monitoring tryptophan emission from the cell, said method comprising the steps of: (a) exposing the epithelial cell to incident ultraviolet wavelengths in order to induce tryptophan present in the epithelial cell to emit an emission pattern, (b) measuring and recording the intensity of the emission pattern of tryptophan to generate a test intensity profile, (c) obtaining a normal emission intensity profile for tryptophan present in a normally proliferating epithelial cell, and comparing said test profile with said normal profile at a wavelength corresponding substantially to the maximum emission wavelength of tryptophan, with any difference in emission of the test profile relative to the normal profile near the maximum emission wavelength of tryptophan indicating abnormal proliferation of the epithelial cell.
Claim 5
Independent Claim
128 words
A method of detecting abnormal epithelial cell proliferation by monitoring tryptophan emission from the cell, said method comprising the steps of: (a) exposing the epithelial cell to incident ultraviolet wavelengths in order to induce tryptophan present in the epithelial cell to emit an emission pattern, (b) measuring and recording the intensity of the emission pattern of tryptophan to generate a test intensity profile, (c) obtaining a normal emission intensity profile for tryptophan present in a normally proliferating epithelial cell, and comparing said test profile with said normal profile at a wavelength corresponding substantially to the maximum emission wavelength of tryptophan, with any difference in emission of the test profile relative to the normal profile near the maximum emission wavelength of tryptophan indicating abnormal proliferation of the epithelial cell.
Claim 6
Dependent Claim
20 words
The method of claim 1 or 3, wherein said set of incident wavelengths includes wavelengths between 260 and 330 nm.
Claim 7
Dependent Claim
17 words
The method of claim 3, wherein said set of wavelengths includes a wavelength of about 295 nm.
Claim 8
Dependent Claim
17 words
The method of claim 1 or 3, wherein said emission wavelength is between 330 and 800 nm.
Claim 9
Dependent Claim
13 words
The method of claim 6, wherein said emission wavelength is about 360 nm.
Claim 10
Dependent Claim
16 words
The method of claim 1 or 3, wherein said abnormal proliferation is faster than normal proliferation.
Claim 11
Dependent Claim
14 words
The method of claim 8, wherein said faster proliferation is an indication of cancer.
Claim 12
Dependent Claim
15 words
The method of claim 8, wherein said faster proliferation is an indication of wound healing.
Claim 13
Dependent Claim
16 words
The method of claim 1 or 3, wherein said abnormal proliferation is slower than normal proliferation.
Claim 14
Dependent Claim
15 words
The method of claim 1 or 3, wherein said epithelial cell is a skin cell.
Claim 15
Dependent Claim
14 words
The method of claim 12, wherein said faster proliferation is an indication of psoriasis.
Claim 16
Dependent Claim
15 words
The method of claim 1 or 3, wherein said epithelial cell is in a patient.
Claim 17
Dependent Claim
11 words
The method of claim 14, wherein said patient is a human.
Claim 18
Dependent Claim
45 words
The method of claim 1 or 3, wherein said method is carried out at a starting point and an ending point of a period of time on the same epithelial cell to obtain a measurement of any variation of abnormal proliferation over said time period.
Claim 19
Dependent Claim
30 words
The method of claim 1 or 3, wherein said normal fluorescence emission intensity profile is obtained by carrying out the method of claim 1 on a normally proliferating epithelial cell.
References Cited (Backward Citations)
US4479499A
Cited
US4957114A
Cited
US4930516A
Cited
US4930516B1
Cited
US4981138A
Cited
US5205291A
Cited
US5345941A
Cited
US5131398A
Cited
US5348018A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-10-09 | 1999-04-10 | 1999-10-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-10-09 | 2003-04-10 | 2003-10-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-10-09 | 2007-04-10 | 2007-10-10 | $7700.00 | Window Closed / Lapsed |